# Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms

> **NCT02309203** · NA · WITHDRAWN · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)**

## Conditions studied

- Intracranial Aneurysms

## Interventions

- **DEVICE:** FRED

## Key facts

- **NCT ID:** NCT02309203
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2017-02
- **Final completion:** 2017-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study not initiated at our site.
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02309203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02309203, "Canadian Study of the MicroVention Flow Re-Direction (FRED) Endoluminal Device Stent System in the Treatment of Intracranial Aneurysms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02309203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*